Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonidegib and paclitaxel in recurrent platinum resistant ovarian cancer
NCT02195973Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label trial of sonidegib in ovarian cancer, sponsored by University of Alabama at Birmingham. Started Sep 2014; status: completed.
02
Drugs
sonidegib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02195973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195973.